Is the new international breakthrough drug for the treatment of Parkinson’s disease Sparsentan/Sparsentan?
Sparsentan is not a drug specifically used to treat Parkinson's disease, but is a new treatment drug for immunoglobulin A nephropathy (IgAN). Therefore, sparsentin does not apply when discussing new breakthroughs in the treatment of Parkinson's disease internationally. Parkinson's disease is a degenerative disease of the nervous system that mainly affects motor function, causing symptoms such as tremor, stiffness, and bradykinesia. Current research and new drug development for Parkinson's disease mainly focus on improving symptoms, delaying disease progression, and protecting nerve cells.

In recent years, research on Parkinson's disease has made some new breakthroughs. For example, some new drugs such as dopamine receptor agonists, MAO-B inhibitors, and other neuroprotective agents are being developed, aiming to improve patients' quality of life through different mechanisms. In addition, emerging treatments such as gene therapy, stem cell therapy and immunotherapy are also in the clinical trial stage and show potential promise.
In the treatment of Parkinson's disease, dopamine replacement therapy is still the most commonly used method, among which levodopa (levodopa) is still regarded as the "gold standard" treatment. However, long-term use of levodopa can cause motor complications, so researchers continue to explore other alternative treatments to reduce these side effects and increase the effectiveness of treatment.
In addition to drug treatment, non-drug treatments are also important, such as physical therapy, occupational therapy and speech therapy. These therapies can help improve patients' overall functioning and enhance their quality of life. In addition, lifestyle changes, such as healthy diet, regular exercise and psychological support, also play a positive role in relieving symptoms and improving the patient's emotional state.
References:https://www.nia.nih.gov/health/parkinsons-disease/parkinsons-disease-causes-symptoms-and-treatments
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)